Fresenius Medical Care (FMS) Competitors

Fresenius Medical Care (NYSE:FMS) and DaVita (NYSE:DVA) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, community ranking, risk and valuation.

Do analysts rate FMS or DVA?

Fresenius Medical Care currently has a consensus price target of $24.00, indicating a potential upside of 12.52%. DaVita has a consensus price target of $144.67, indicating a potential upside of 1.04%. Given Fresenius Medical Care's higher probable upside, equities analysts plainly believe Fresenius Medical Care is more favorable than DaVita.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care	1 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.14
DaVita	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Do institutionals & insiders hold more shares of FMS or DVA?

8.3% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 2.0% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, FMS or DVA?

Fresenius Medical Care has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Comparatively, DaVita has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.

Does the MarketBeat Community prefer FMS or DVA?

DaVita received 87 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 61.80% of users gave DaVita an outperform vote while only 54.11% of users gave Fresenius Medical Care an outperform vote.

Company	Underperform	Outperform
Fresenius Medical Care	Outperform Votes 408 54.11%	Underperform Votes 346 45.89%
DaVita	Outperform Votes 495 61.80%	Underperform Votes 306 38.20%

Does the media refer more to FMS or DVA?

In the previous week, DaVita had 4 more articles in the media than Fresenius Medical Care. MarketBeat recorded 6 mentions for DaVita and 2 mentions for Fresenius Medical Care. DaVita's average media sentiment score of 0.98 beat Fresenius Medical Care's score of 0.95 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is FMS or DVA more profitable?

DaVita has a net margin of 6.61% compared to Fresenius Medical Care's net margin of 2.48%. DaVita's return on equity of 68.52% beat Fresenius Medical Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care	2.48%	5.29%	2.30%
DaVita	6.61%	68.52%	4.98%

Which has higher valuation and earnings, FMS or DVA?

DaVita has lower revenue, but higher earnings than Fresenius Medical Care. DaVita is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care	$21.05B	0.59	$540.07M	$0.89	23.97
DaVita	$12.14B	1.03	$691.53M	$8.80	16.27

Summary

DaVita beats Fresenius Medical Care on 14 of the 18 factors compared between the two stocks.